Related Experiment Videos
S100B and cardiac surgery: possibilities and limitations.
1Department of Cardiothoracic Surgery, University Hospital Lund, SE-221 85 Lund, Sweden. henrik.jonsson@thorax.lu.se
Restorative Neurology and Neuroscience
|October 8, 2003
Summary
Serum glial protein S100B levels correlate with brain damage and long-term outcomes after cardiac surgery. Later S100B measurements predict survival, while early levels show less correlation due to potential blood contamination.
Area of Science:
- Neuroscience
- Biochemistry
- Cardiology
Background:
- Serum S100B protein is a potential biomarker for brain injury.
- Cardiac surgery can lead to neurological complications.
Purpose of the Study:
- To investigate the correlation between S100B levels and brain damage/outcomes post-cardiac surgery.
- To evaluate S100B as a predictor of neurological injury and survival.
Main Methods:
- Serum S100B levels were measured at various time points after cardiac surgery.
- Correlations were analyzed between S100B levels and indicators of brain damage (infarction) and cognitive decline.
- Long-term survival data was compared with S100B levels.
Main Results:
- Elevated S100B levels 48 hours post-surgery correlated with brain infarction presence and extent.
- Higher S100B levels predicted decreased long-term survival.
- Early S100B measurements (2-8 hours) showed inconsistent correlation with cognitive decline, possibly due to blood contamination.
Conclusions:
- Serum S100B is a valuable biomarker for detecting brain damage and predicting outcomes after cardiac surgery.
- Timing of S100B measurement is crucial for accurate correlation with neurological complications.
- Further research is needed to clarify the role of early S100B measurements.